We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

118 hedge funds and large institutions have $666M invested in Dyne Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 57 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 28

6% more capital invested

Capital invested by funds: $629M → $666M (+$37.1M)

4.55% more ownership

Funds ownership: 96.96% → 101.51% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less funds holding

Funds holding: 127 → 118 (-9)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

74% less call options, than puts

Call options by funds: $46K | Put options by funds: $179K

Holders
118
Holders Change
-9
Holders Change %
-7.09%
% of All Funds
1.85%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
57
Reduced
28
Closed
24
Calls
$46K
Puts
$179K
Net Calls
-$133K
Net Calls Change
-$304K

Top Buyers

1
VA
VR Adviser
New York
+$25.6M
2
State Street
State Street
Massachusetts
+$13.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
4
AC
Armistice Capital
New York
+$10.8M
5
BlackRock
BlackRock
New York
+$8.29M

Top Sellers

1
EC
EcoR1 Capital
California
-$18M
2
WA
Wasatch Advisors
Utah
-$7.88M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.81M
5
HA
HHLR Advisors
Cayman Islands
-$5.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
26
Vivo Capital
California
$6.5M – – –
Ensign Peak Advisors
27
Ensign Peak Advisors
Utah
$5.75M +$3.36M +284,667 +126%
PCH
28
Polar Capital Holdings
United Kingdom
$5.63M +$5.9M +500,000 New
Axa
29
Axa
France
$5.37M +$633K +53,617 +13%
SI
30
Sofinnova Investments
California
$4.96M +$5.2M +441,048 New
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$4.82M -$5.81M -492,606 -53%
WP
32
Woodline Partners
California
$4.3M +$4.51M +382,576 New
ACH
33
ArrowMark Colorado Holdings
Colorado
$4.3M +$1.27M +107,252 +39%
Northern Trust
34
Northern Trust
Illinois
$4.29M +$1.26M +106,455 +39%
AllianceBernstein
35
AllianceBernstein
Tennessee
$4.12M +$445K +37,713 +11%
IBT
36
International Biotechnology Trust
United Kingdom
$3.38M -$1.57M -133,000 -31%
Charles Schwab
37
Charles Schwab
California
$3.21M +$679K +57,537 +25%
AG
38
Algert Global
California
$2.69M +$557K +47,200 +25%
Norges Bank
39
Norges Bank
Norway
$2.2M -$1.98M -168,000 -46%
UOC
40
UBS O'Connor
Illinois
$1.98M -$10K -849 -0.5%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$1.81M -$892K -75,600 -32%
ACM
42
Altium Capital Management
New York
$1.74M – – –
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.69M +$276K +23,384 +18%
N
44
Nuveen
North Carolina
$1.68M +$169K +14,360 +11%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$1.36M +$786K +66,591 +123%
SFM
46
Sphera Funds Management
Israel
$1.35M -$1.17M -99,398 -45%
Rafferty Asset Management
47
Rafferty Asset Management
New York
$1.32M +$1.38M +117,264 New
Morgan Stanley
48
Morgan Stanley
New York
$1.29M +$14.3K +1,215 +1%
Russell Investments Group
49
Russell Investments Group
United Kingdom
$1.25M +$1.03M +87,678 +371%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.24M +$405K +34,345 +45%
1
2
3 4 5

DYN Hedge Fund Activity: Q2 2023 in Review

118 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2023, worth a combined $666M — up 5.9% from $629M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of DYN and 15 opened new positions — a net loss of 9 holders — while 28 trimmed existing stakes and 57 added.

The largest buyer was VR Adviser, opening a new position worth an estimated $25.6M. The largest seller was EcoR1 Capital, cutting an estimated $18M.

  • 118 institutional investors held Dyne Therapeutics (DYN) as of Q2 2023, down from 127 in Q1 2023.
  • Funds reported $666M of Dyne Therapeutics stock for Q2 2023, up 5.9% quarter-over-quarter.
  • 15 funds opened new Dyne Therapeutics positions in Q2 2023 and 24 closed out, a net change of -9 holders.
  • The largest Dyne Therapeutics buyer in Q2 2023 was VR Adviser, an estimated $25.6M added.
  • The largest Dyne Therapeutics seller in Q2 2023 was EcoR1 Capital, an estimated $18M sold.

Based on aggregated 13F filings for Q2 2023.